Episode 5 is now live. This episode discusses the federal guidelines and California laws regulating how retail pricing should be displayed and what fees and charges need to be disclosed upfront and how to best mitigate against the risk of litigation or enforcement actions being pursued. 

Watch Episode 5 Here:

Subscribe to the Consumer Class Defense Blog today and get notified when each new vidcast goes live.

Episode 4 is now live. In this episode of Consumer Counterpoint, we discuss the recent Supreme Court decision in McLaughlin Chiropractic Associates v. McKesson Corporation and the district courts that are reassessing the statutory interpretation of certain TCPA provisions where the previously accepted interpretations came from FCC Orders. Watch Episode 4 Here: Subscribe to the Consumer Class Defense Blog today and get notified when each new vidcast goes live.

Episode 3 is now live. Episode three focuses on the Illinois Biometric Information Privacy Act (BIPA), a law that has generated significant litigation and compliance challenges over the past several years. In the episode, we discuss the history of BIPA, recent litigation trends, key court decisions, and common strategic defenses. We also look ahead to the issues expected to come to the forefront in 2026 and what businesses should consider now to ensure compliance.

Watch Episode 3 Here:

Subscribe to the Consumer Class Defense Blog today and get notified when each new vidcast goes live.

Episode 2 is now live. Episode two covers the very recent amendments to Texas’ telemarketing laws which became effective September 1. In the episode we discuss the increasing frequency with which states are amending their telemarketing laws to include requirements that are more aligned with or stricter than the TCPA and to add a private right of action. We discuss the specific changes to the Texas statute and how companies marketing in Texas and to Texas residents can comply.

Watch Episode 2 Here:

Subscribe to the Consumer Class Defense Blog today and get notified when each new vidcast goes live.

We’re excited to launch Consumer Counterpoint, a new vidcast series from Seyfarth’s Consumer Class Defense Blog.

Hosted by Kristine Argentine, Chair of Seyfarth’s Consumer Class Action Defense practice, and attorney Paul Yovanic, the series provides concise, practical insights into the consumer litigation issues shaping today’s marketplace.

In just 15 minutes, Kristine, Paul, and other Seyfarth attorneys will explore topics such as:

  • Advertising and pricing claims
  • Biometric privacy
  • Digital fraud
  • Financial services litigation
  • And other emerging areas in consumer class action defense

Episode 1 is now live. Episode 1 will cover the trending class action cases involving the use of tracking technologies on websites and whether or not the use of those technologies can constitute a violation of wiretap statutes and other privacy laws.  In the episode we will cover the evolution of these cases and types of steps companies can take to mitigate the risks and lessen the potential exposure created by these claims.  

Watch Episode 1 here:

Subscribe to the Consumer Class Defense Blog today and get notified when each new vidcast goes live.

Originally posted to Seyfarth’s Workplace Class Action blog.

Seyfarth Synopsis: On June 5, 2025, the U.S. Supreme Court changed course and dismissed the writ of certiorari that it previously had granted in Laboratory Corporation of America Holdings v. Davis, No. 24-304 (U.S. June 5, 2025).  In doing so, the Supreme Court passed on the chance to decide the question that had been presented, namely: whether federal courts may certify a Rule 23 damages class that includes both injured and uninjured members.  These sorts of issues are frequently litigated in the employment context.  The Supreme Court’s decision is not helpful to employers in the near term, since it does not restrict these class actions as a rule in federal court.  However, the Supreme Court has not closed the door on revisiting the issue, and the inclusion of uninjured class members can still provide grounds for defendants to oppose certification in the meantime. 

Case Background

Defendant Labcorp offered patients on-site, self-service, touchscreen kiosks to check in for their appointments at its patient service centers.  These touchscreen kiosks were offered in addition to either checking in at the front desk or the online check-in process that patients could complete before they arrived.  The kiosks were not accessible to blind patients unless the patients had assistance.  To address the accessibility issue, Labcorp ensured that its patient service centers had at least one employee available who could check in patients at the front desk using the same technology used in the kiosks.     

Luke Davis and Julian Vargas—both of whom are legally blind—filed a class action against Labcorp under Title III of the Americans with Disabilities Act (“ADA”) and the California Unruh Civil Rights Act (“Unruh Act”), which considers violations of the ADA to constitute violations of the state law and provides for a minimum of $4,000 in damages for each offense.  The plaintiffs alleged that Labcorp denied them and other blind individuals full and equal access to the patient service centers because the kiosks were inaccessible to them.  However, the record indicated that many class members were not actually harmed by Labcorp’s new kiosks on account of not being able to use them because, for instance, they would prefer to use the front desk anyway.

The district court certified a class of potentially more than 100,000 blind individuals seeking nearly $500 million in damages under the Unruh Act per year.  While Labcorp’s petition for interlocutory appeal was pending with the Court of Appeals for the Ninth Circuit, the district court clarified the class definition without materially altering the composition of the class or changing its original class certification order, which the Ninth Circuit subsequently affirmed.

The Supreme Court’s Decision

The U.S. Supreme Court initially granted certiorari to decide whether a federal court may certify a class action pursuant to Federal Rule of Civil Procedure 23(b)(3) when some members of the proposed class lack any Article III injury.  Before reaching the question, however, in a single-sentence per curiam decision, the Supreme Court reversed course and ordered that the writ of certiorari was dismissed as “improvidently granted.”  Those eagerly awaiting the answer to the question are now left to wait for the next test case.

Justice Kavanaugh, in the lone dissent, raised some frustrations likely to be shared by those left waiting.  Presuming that his colleagues did not “want to deal with” the plaintiffs’ threshold argument that the matter was moot because the district court’s original class certification order was supplanted by its subsequent order clarifying the class definition, Justice Kavanaugh rejected the argument as “insubstantial” as, among other things, the subsequent order did not materially change the original order that actually granted class certification and that Labcorp appealed. 

Justice Kavanaugh also addressed the merits with respect to the question presented.  Justice Kavanaugh characterized the case as “straightforward” under Rule 23 and the Supreme Court’s precedents.  While Rule 23 requires that common questions predominate in damages class actions, common questions do not predominate in a class consisting of both injured and uninjured members.  Justice Kavanaugh also agreed with the United States, which had joined as amicus curiae, that “if there are members of a class that aren’t even injured, they can’t share the same injury with the other class members.”  Justice Kavanaugh also clearly signaled where he will stand if the issue reaches the Supreme Court in the future; he would have held that federal courts may not certify a proposed damages class under Rule 23 when the class includes both injured and uninjured members.

Justice Kavanaugh warned that the Ninth Circuit’s decision to the contrary will “generate serious and real-world consequences.”  Pointing to the half a billion dollars a year that Labcorp was facing in potential damages, Justice Kavanaugh explained that classes “overinflated with uninjured members” can force companies into agreeing to “costly settlements” under the threat of “massive liability.”  In turn, companies pass on these costs to consumers, retirement account holders, and workers, ultimately harming each of these groups, among others. 

Implications For Employers

This decision had the potential to significantly limit class actions in federal court.  As Labcorp noted in its petition for a writ of certiorari, “around 10,000” class action lawsuits are filed annually.  Citing Seyfarth’s ADA Title III blog, Labcorp also pointed out that half of the recent record high in ADA cases like its own were filed in California, where plaintiffs may attempt to recover statutory damages under the Unruh Act based on a purported violation of the ADA, even if the plaintiffs were not actually injured.  And while not pertinent to Labcorp’s argument, it is also true that these issues are frequently litigated in the employment context. 

Although the Supreme Court’s ruling was anticlimactic, the question is likely to resurface, and very well may regain traction.  There remains a circuit split over the issue.  And, although he did not cite it in his dissent, Justice Kavanaugh’s majority opinion in TransUnion LLC v. Ramirez—in which the Supreme Court held that every class member must have Article III standing to recover individual damages—was joined by four of his colleagues who are still on the bench. 

In the meantime, employers and other corporate defendants of class actions should continue to consider the issue in crafting their defense strategy.  For example, evidence concerning uninjured class members may reveal that whether members of a proposed class were injured raises evidentiary questions that likely will vary by class member, which individualized inquires may predominate and preclude class certification. 

On June 3, 2025, the California Senate unanimously passed Senate Bill 690 (SB 690), a bill that seeks to add a “commercial business purposes” exception to the California Invasion of Privacy Act (CIPA).

After multiple readings on the Senate floor, SB 690 passed as amended, and will now proceed to the California State Assembly. SB 690, as originally drafted, was explicitly made retroactive to any cases pending as of January 1, 2026.  The most recent amendments on the Senate floor remove the retroactivity provisions, meaning the bill, if passed by the Assembly and signed by the Governor, will only apply prospectively.  The amendments to remove the retroactive provisions of SB 690 are not unexpected. Retroactive application provisions are traditionally frowned upon by the California legislature and may offend due process principles.

If passed, SB 690 would exempt the use of certain online tracking technologies from violating CIPA, provided they are used for a “commercial business purpose” and comply with existing privacy laws like the California Consumer Privacy Act (CCPA).  SB 690 could significantly impact prospective litigation under CIPA for online business activities.  Indeed, there may be the proverbial “rush to the courthouse” if plaintiffs and plaintiffs’ attorneys begin to feel that passage of SB 690 is forthcoming or likely, now that the bill will proceed to the State Assembly.

Businesses may want to consider engaging their government relations teams or contacting members of the California State Assembly to express their positions on the bill as it now passes to the other chamber of the California legislature.

On May 19, 2025, the California Senate Appropriations Committee, which handles budgetary and financial matters, held a hearing on California Senate Bill 690 (SB 690).  The proposed bill would amend the California Invasion of Privacy Act (CIPA) by adding an exception to the statute which has the effect of permitting use of tracking technologies for “commercial business purposes.”

The Appropriations Committee referred SB 690 to the Suspense File.  Generally, if the cost of a bill meets certain fiscal thresholds, the Appropriations Committee will refer the bill to the Suspense File.  Having met that threshold, SB 690 will now proceed to a vote-only Suspense Hearing to be held on May 23, 2025.  No testimony will be heard during the May 23, 2025 hearing.  SB 690 will then either move on to the Senate Floor, or be held in committee.  While referral to the Suspense File is not necessarily a death knell to SB 690, statistics show that a number of bills die quietly in the Suspense Hearing due, in part, to its non-public process. 

If passed, SB 690 would exempt the use of such online tracking technologies from violating CIPA, provided they are used for a “commercial business purpose” and comply with existing privacy laws like the California Consumer Privacy Act (CCPA).  SB 690 could significantly impact current litigation under CIPA for online business activities. Not only will plaintiffs be far less likely to file new lawsuits alleging violations of CIPA, but SB 690’s provisions are explicitly made retroactive to any cases pending as of January 1, 2026, which could lead to dismissals of ongoing lawsuits, as well.

Businesses may want to consider engaging their government relations teams or contacting members of the Senate Appropriations Committee to express their positions on the bill. 

This post was originally published to Seyfarth’s Global Privacy Watch blog.

California Senate Bill 690 (SB 690), introduced by Senator Anna Caballero, is continuing to proceed through the California state legislative process. The proposed bill would amend the California Invasion of Privacy Act (CIPA) by adding an exception to the statute which has the effect of permitting use of tracking technologies for “commercial business purposes.” CIPA, enacted in 1967, was originally established to prohibit the unauthorized recording of or eavesdropping on confidential communications, including telephone calls and other forms of electronic communication. However, over recent years CIPA claims in lawsuits have been used to target business’ online use of cookies, pixels, trackers, chatbots, and session replay tools on their websites. 

If passed, SB 690 would exempt the use of such online tracking technologies from violating CIPA, provided they are used for a “commercial business purpose” and comply with existing privacy laws like the California Consumer Privacy Act (CCPA).  SB 690 could significantly impact current litigation under CIPA for online business activities. Not only will plaintiffs be far less likely to file new lawsuits alleging violations of CIPA, but SB 690’s provisions are explicitly made retroactive to any cases pending as of January 1, 2026, which could lead to dismissals of ongoing lawsuits, as well.

On April 29, 2025, the Senate Public Safety Committee unanimously voted to advance SB 690, and it was subsequently re-referred to the Senate Appropriations Committee. A hearing before the Appropriations Committee is currently scheduled for May 19, 2025.

We are pleased to share that Seyfarth attorneys Paul Yovanic, Jason Priebe, Ada Dolph, and Michael Jacobsen co-authored the “USA – Illinois: Trends & Developments” section in the recently released Chambers Data Protection & Privacy Global Practice Guide 2025. This highly regarded publication provides timely insights and analysis on key developments in data privacy and cybersecurity law across jurisdictions worldwide.

In their chapter, Paul, Jason, Ada, and Michael examine the rapidly evolving privacy landscape in Illinois, including:

  • The latest trends in litigation under the Biometric Information Privacy Act (BIPA)
  • Expanding protections under the Genetic Information Privacy Act (GIPA)
  • The emerging regulation of artificial intelligence in the workplace

Their analysis offers practical guidance for businesses seeking to navigate these complex and developing areas of law, while also reflecting the breadth of Seyfarth’s national capabilities in privacy, technology, and workplace compliance.

As legal scrutiny around biometric data, genetic information, and workplace technologies continues to intensify, staying ahead of these issues is critical. Our attorneys’ contribution to this leading publication demonstrates Seyfarth’s position at the forefront of data privacy law and our commitment to helping clients manage risk in an increasingly digital world.

For those confronting the challenges of data protection, biometric compliance, and AI regulation, the Chambers Data Protection & Privacy Global Practice Guide is an essential resource.

Read the full guide here: Chambers Global Practice Guide: USA – Illinois Chapter